However, several other known acute-phase reactants were found not to be elevated (e.g., AHSG, SERPINA3, ITIH4, FN, F2, F8, SAP, and CD163), arguing that there may be some specificity in the inflammatory response to pancreatic cancer. This evidence concerns the gene FN1 and familial pancreatic carcinoma.